Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Shares Outstanding (Weighted Average) (2016 - 2025)

Bioceres Crop Solutions' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $42.3 million for Q2 2022.

  • For Q2 2022, Shares Outstanding (Weighted Average) rose 7.86% year-over-year to $42.3 million; the TTM value through Jun 2022 reached $42.3 million, up 7.86%, while the annual FY2022 figure was $42.3 million, 7.86% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2022 was $42.3 million at Bioceres Crop Solutions, up from $39.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $42.3 million in Q2 2022 and bottomed at $28.1 million in Q2 2018.
  • The 5-year median for Shares Outstanding (Weighted Average) is $36.1 million (2020), against an average of $35.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) changed 0.0% in 2018 before it grew 18.51% in 2020.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $28.1 million in 2018, then rose by 8.47% to $30.5 million in 2019, then rose by 18.51% to $36.1 million in 2020, then increased by 8.58% to $39.2 million in 2021, then rose by 7.86% to $42.3 million in 2022.
  • Per Business Quant, the three most recent readings for BIOX's Shares Outstanding (Weighted Average) are $42.3 million (Q2 2022), $39.2 million (Q2 2021), and $36.1 million (Q2 2020).